Viktor Ivanovich Roschin,Vagif Sultanovich Sultanov
申请号：
US12601377
公开号：
US08987338B2
申请日:
2008.05.14
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to an area of the chemical-pharmaceutical industry and medicine, particularly to an agent for treatment of dementias, including Alzheimers disease (AD), as well as to a method of treatment and pharmaceutical composition, which is effective for both treatment of dementias, including AD or dementias of Alzheimer type, and during manifestations of the first symptoms of memory disorder.The given invention consists of the development of a new therapeutic substance with minimal side effects that currently is a topical issue for treatment of the corresponding diseases.Attached is the use of polyprenols of formula (1)where n=8-20as an active ingredient for the production of the therapeutic agent for the treatment of patients with dementia syndrome, including those who suffer from Alzheimers disease.It is proposed to use a therapeutic agent for the treatment of patients with dementia syndrome, including those suffering from Alzheimers disease, being polyprenols of formula (1).It was proposed that a pharmaceutical composition for the treatment of patients suffering from dementia syndrome, including patients suffering from Alzheimer disease, being an effective amount of polyprenols of formula (1) and pharmaceutically acceptable additional substances, including carriers and/or solvents, additives and/or lubricants.It was proposed that a method for treatment of patients suffering from dementia syndrome, including patients suffering from Alzheimers disease, when effective amount of polyprenols of formula (1) is administered in the form of the substance or as a pharmaceutical composition that includes additional components.
